Icahn Enterprises has decided to sell its casino venture Tropicana Entertainment (TPCA) to Gaming and Leisure Properties (GLPI) and Eldorado Resorts (ERI) for $1.85 billion. The billionaire investor’s firm owns a majority stake in Tropicana (84%). As part of the deal, Tropicana will be selling seven casinos out of the eight casinos it currently operates.
Gaming and Leisure Properties will be paying $1.21 billion and the rest coming from Eldorado Resorts. Also, Gaming and Leisure has decided to lease the acquired properties to Eldorado for 15 years. Aruba Resort is not part of the deal, as Tropicana plans to divest the property before the closing of GLPI deal.
Carl Icahn is known for his uncanny ability to pick up assets which are dirt cheap or commanding low valuation. He turnaround those assets and sells them at an appropriate time for a massive windfall. As is the case, Icahn bought Tropicana in 2008 which was under bankruptcy. He appointed Tony Rodio to run the operations. It’s worth noting, at the end of last year, Tropicana’s revenue was $898 million with its flagship property Tropicana Atlantic City bringing in $390 million to its kitty.
Expanding footprint
Eldorado currently manages 20 properties in the U.S. Post this deal, it gains seven more properties and expands its footprint to two more states. The company has been on a buying spree for past few years. Last year, the company bought a casino based in Reno for $1.1 billion, and on Monday it also gobbled up a casino based in Elgin, Illinois for $327.5 million. It seems the gambling industry is up for consolidation.
Thumbs up from the market
Subject to the approval of the boards, the Tropicana deal is expected to close by the end of 2018. It seems investors are gung-ho about the deal. After the market closed on Monday, Tropicana’s share has gained 27%, while Eldorado and GLPI’s shares have gained 16% and 4%.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on